About SATYA Pharma Innovations
SATYA Pharma Innovations is a Healthcare company based in Hyderabad (India) founded in 2019 by Murthy Chavali. It develops innovative small molecule technologies for cancer treatment. It operates on a B2B model. The company has 38 employees. Its chief executive, as recorded, is Murthy Chavali. Its Indian entity Satyarx Pharma Innovations Private Limited reported revenue of ₹7.55 Cr. Its focus areas include Biotechnology, Pharmaceuticals and Cancer Treatment.
Company details
SATYA Pharma Innovations, established in 2019, excels in providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer treatment. Develops innovative small molecule technologies for cancer treatment. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Hyderabad, India
- Employees 38
- Founders Murthy Chavali
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website satyarx.com
- Legal Name Satyarx Pharma Innovations Private Limited
- Date of Incorporation 08 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹7.55 Cr
FY 2025 · +24% YoY
- Net Loss-₹1.84 Cr
FY 2025 · -24% margin
- EBITDA-₹1.00 Cr
FY 2025 · -13% margin
- Employee Count38
Associated legal entities of SATYA Pharma Innovations
SATYA Pharma Innovations is associated with 2 registered companies on The Company Check; the primary company is Satyarx Pharma Innovations Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Satyarx Pharma Innovations Private Limited CIN U73100TG2020PTC142629 | Active | 08 Aug 2020 | Hyderabad, Telangana | ₹7.5 Cr | 47 | 3 | View details |
| Satyarx Pharma Innovations Llp CIN AAQ-9451 | Converted To Cmp And Dissolved | 04 Nov 2019 | Hyderabad, Telangana | 2 | View details |
Board of directors of Satyarx Pharma Innovations Private Limited (SATYA Pharma Innovations)
Satyarx Pharma Innovations Private Limited is the primary company behind SATYA Pharma Innovations. The boards of the 2 registered companies of SATYA Pharma Innovations currently have 3 directors; the longest-serving is Satyanarayana Murthy Chavali, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satyanarayana Murthy Chavali DIN 00142138 | Designated Partner | 04 Nov 2019 | 7 yrs | Satyarx Pharma Innovations Llp, Satyarx Pharma Innovations Private Limited |
| Saroja Chavali DIN 08601469 | Designated Partner | 04 Nov 2019 | 7 yrs | Satyarx Pharma Innovations Llp, Satyarx Pharma Innovations Private Limited |
| Ande Pratap Reddy DIN 00003967 | Director | 16 Nov 2020 | 5 yrs 11 mo | Satyarx Pharma Innovations Private Limited |
People of SATYA Pharma Innovations
1 people are tracked at SATYA Pharma Innovations (1 in leadership); the tracked headcount is 38.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for SATYA Pharma Innovations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SATYA Pharma Innovations
Figures of Satyarx Pharma Innovations Private Limited, the primary company behind SATYA Pharma Innovations, for FY 2025. Revenue was ₹7.55 Cr (+24% year on year). Net loss was -₹1.84 Cr (-24% margin). EBITDA was -₹1.00 Cr (-13% margin). Revenue has grown at a compounded annual rate of +298% over three years and -2% over five years.
- ₹7.55 CrRevenue · FY 2025 · +24% YoY
- -₹1.84 CrNet loss · -24% margin
- -₹1.00 CrEBITDA · -13% margin
- ₹9.94 CrPaid-up capital
- 47Employees (provident fund records)
- +298%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Satyarx Pharma Innovations Private Limited are on its company page.
Detailed financial statements for SATYA Pharma Innovations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Satya Pharma Innovations
Complete news archive for SATYA Pharma Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SATYA Pharma Innovations
SATYA Pharma Innovations was founded in 2019.
SATYA Pharma Innovations is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Murthy Chavali is the CEO of SATYA Pharma Innovations, as recorded in our data. They have also founded this company.
SATYA Pharma Innovations has 38 employees.
The primary company behind SATYA Pharma Innovations, Satyarx Pharma Innovations Private Limited, reported revenue of ₹7.55 Cr for FY 2025, up 24% year on year.
SATYA Pharma Innovations, established in 2019, excels in providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer treatment. Develops innovative small molecule technologies for cancer treatment. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
SATYA Pharma Innovations is associated with 2 legal entities: Satyarx Pharma Innovations Private Limited, Satyarx Pharma Innovations Llp.
The legal entities of SATYA Pharma Innovations currently have 3 directors, including Satyanarayana Murthy Chavali, Saroja Chavali, Ande Pratap Reddy.